News on qPCR, digital PCR, amplification, point-of-care testing platforms in genetics, genomics, and molecular diagnostics.
The agreement enables NeuMoDx to bring sample-to-result HPV screening to customers in Europe, where its systems are distributed by Qiagen.
The firm said that its newly CE-marked test for intestinal infections is suitable for use in laboratories and hospitals, and provides results in 90 minutes.
The in vitro diagnostic test can deliver molecular results from whole blood samples in less than three hours, the company said.
The FDA clearance follows earlier US marketing approval for the firm's C. Difficile assay.
The director of the Biomedical Advanced Research and Development Authority has launched two new funding programs in the past three years.
